Arachidonic Acid News and Research

RSS
Arachidonic acid is an omega-6 fatty acid that is present in the phospholipids (especially phosphatidylethanolamine, phosphatidylcholine and phosphatidylinositides) of membranes of the body's cells, and is abundant in the brain. It is the counterpart to the saturated arachidic acid found in peanut oil.
PUFA levels reduced in schizophrenia patients

PUFA levels reduced in schizophrenia patients

PUFA levels reduced in schizophrenia patients

PUFA levels reduced in schizophrenia patients

PUFA levels reduced in schizophrenia patients

PUFA levels reduced in schizophrenia patients

New DHA and ARA source suitable for supplementation of infant formulas

New DHA and ARA source suitable for supplementation of infant formulas

Researchers map processes that power health benefits of omega-3 fatty acids

Researchers map processes that power health benefits of omega-3 fatty acids

Study confirms that COX-2 inhibitors predispose people to cardiovascular disease

Study confirms that COX-2 inhibitors predispose people to cardiovascular disease

New imaging tool reveals subtle changes in breast tissue

New imaging tool reveals subtle changes in breast tissue

Study refutes perinatal programming theory about adipose tissue growth

Study refutes perinatal programming theory about adipose tissue growth

New metabolic pathway for controlling brain inflammation

New metabolic pathway for controlling brain inflammation

New insights into actions of NSAIDs

New insights into actions of NSAIDs

Infant formulas fortified with LCPUFA are good for developing brains and hearts

Infant formulas fortified with LCPUFA are good for developing brains and hearts

Omega-3s decreases severity of brain damage after stroke

Omega-3s decreases severity of brain damage after stroke

Research reveals how humans of different ancestry process polyunsaturated fat

Research reveals how humans of different ancestry process polyunsaturated fat

Researchers discover new avenue for hypertension, cardiovascular disease treatment

Researchers discover new avenue for hypertension, cardiovascular disease treatment

Orexo partner ProStrakan launches Abstral in the US

Orexo partner ProStrakan launches Abstral in the US

Positive outcome from Orexo's OX51 initial pharmacokinetic trial to treat acute intensive pain

Positive outcome from Orexo's OX51 initial pharmacokinetic trial to treat acute intensive pain

Health Canada approves Orexo's Abstral to treat chronic cancer pain

Health Canada approves Orexo's Abstral to treat chronic cancer pain

Orexo fourth quarter net revenues increase to MSEK 109.1

Orexo fourth quarter net revenues increase to MSEK 109.1

Orexo, Invida enter exclusive licensing and distribution agreement for Abstral in Asia Pacific

Orexo, Invida enter exclusive licensing and distribution agreement for Abstral in Asia Pacific

12-HETE enzyme inhibition can prevent ischemic retinopathy: Study

12-HETE enzyme inhibition can prevent ischemic retinopathy: Study